Non-syndromic congenital hypogonadotropic hypogonadism: Clinical presentation and genotype-phenotype relationships

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 835-851

  Brioude, Frédéric ^a,b,c   Bouligand, Jérôme ^a,b,c   Trabado, Séverine ^a,b,c   Francou, Bruno ^a,b,c   Salenave, Sylvie ^b   Kamenicky, Peter ^a,b   Brailly Tabard, Sylvie ^a,b,c   Chanson, Philippe ^a,b   Guiochon Mantel, Anne ^a,b,c   Young, Jacques ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

^c Service de Génétique Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GESTAGEN; GONADORELIN; GONADORELIN RECEPTOR; GONADOTROPIN; KISSPEPTIN; LUTEINIZING HORMONE; NEUROKININ 3 RECEPTOR; NEUROKININ B; NUCLEAR RECEPTOR DAX 1; TESTOSTERONE;

BARDET BIEDL SYNDROME; BLOOD SAMPLING; CLINICAL FEATURE; ESTRADIOL BLOOD LEVEL; GENOTYPE; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; GORDON SYNDROME; GYNECOMASTIA; HETEROZYGOTE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; KALLMANN SYNDROME; LOSS OF FUNCTION MUTATION; LUTEINIZING HORMONE RELEASE; MISSENSE MUTATION; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PHENOTYPE; PRADER WILLI SYNDROME; PRIMARY AMENORRHEA; PRIORITY JOURNAL; REVIEW; SYNDROME CHARGE; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; AMENORRHEA; FEMALE; GENOTYPE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOGONADISM; INFANT; KALLMANN SYNDROME; MALE; NEUROKININ B; PHENOTYPE; PROTEIN PRECURSORS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LHRH; RECEPTORS, NEUROKININ-3; TESTOSTERONE;

EID: 77951665082     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0083     Document Type: Review

References (132)

1. Fromantin M, Gineste J, Didier A & Rouvier J. Impuberism and hypogonadism at induction into military service. Statistical study. Problèmes Actuels d'Endocrinologie et de Nutrition 1973 16 179-199.
2. Seminara SB, Hayes FJ & Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocrine Reviews 1998 19 521-539.
3. Quinton R, Duke VM, Robertson A, Kirk JM, Matfin G, de Zoysa PA, Azcona C, MacColl GS, Jacobs HS, Conway GS, Besser M, Stanhope RG & Bouloux PM. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clinical Endocrinology 2001 55 163-174.
4. Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G, Enjalbert A, Valensi P & Brue T. An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. Journal of Clinical Endocrinology and Metabolism 2005 90 4880-4887.
5. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A & Amselem S. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics 2000 25 182-186.
6. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, Jameson JL & Achermann JC. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. Journal of Clinical Endocrinology and Metabolism 2006 91 3048-3054.
7. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P & Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 392 398-401.
8. Strobel A, Issad T, Camoin L, Ozata M & Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genetics 1998 18 213-215.
9. Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ & O'Rahilly S. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. Journal of Clinical Investigation 2003 112 1550-1560.
10. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC & Tauber M. Recommendations for the diagnosis and management of Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 4183-4197.
11. Dollfus H, Verloes A, Bonneau D, Cossee M, Perrin-Schmitt F, Brandt C, Flament J & Mandel JL. Update on Bardet-Biedl syndrome. Journal of Français d'Ophtalmologie 2005 28 106-112.
12. Quinton R, Barnett P, Coskeran P & Bouloux PM. Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormone. Clinical Endocrinology 1999 51 525-529.
13. Seminara SB, Acierno JS Jr, Abdulwahid NA, Crowley WF Jr & Margolin DH. Hypogonadotropic hypogonadism and cerebellar ataxia: detailed phenotypic characterization of a large, extended kindred. Journal of Clinical Endocrinology and Metabolism 2002 87 1607-1612.
14. Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, Hertz- Pannier L, Bertrand AM, Lyonnet S, Rappaport R & Netchine I. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. Journal of Clinical Endocrinology and Metabolism 2005 90 5621-5626.
15. Kim HG, Bhagavath B & Layman LC. Clinical manifestations of impaired GnRH neuron development and function. Neuro-Signals 2008 16 165-182.
16. Trarbach EB, Silveira LG & Latronico AC. Genetic insights into human isolated gonadotropin deficiency. Pituitary 2007 10 381-391.
17. Hardelin JP & Dode C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sexual Development 2008 2 181-193.
18. Salenave S, Chanson P, Bry H, Pugeat M, Cabrol S, Carel JC, Murat A, Lecomte P, Brailly S, Hardelin JP, Dode C & Young J. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. Journal of Clinical Endocrinology and Metabolism 2008 93 758-763.
19. Arnhold IJ, Lofrano-Porto A & Latronico AC. Inactivating mutations of luteinizing hormone beta-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Hormone Research 2009 71 75-82.
20. Forest MG & Cathiard AM. Pattern of plasma testosterone and delta4-androstenedione in normal newborns: evidence for testicular activity at birth. Journal of Clinical Endocrinology and Metabolism 1975 41 977-980.
21. Evain-Brion D, Gendrel D, Bozzola M, Chaussain JL & Job JC. Diagnosis of Kallmann's syndrome in early infancy. Acta Paediatrica Scandinavica 1982 71 937-940. (Pubitemid 12006566)
22. Grumbach MM. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. Journal of Clinical Endocrinology and Metabolism 2005 90 3122-3127.
23. Bergada I, Milani C, Bedecarras P, Andreone L, Ropelato MG, Gottlieb S, Bergada C, Campo S & Rey RA. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. Journal of Clinical Endocrinology and Metabolism 2006 91 4092-4098. (Pubitemid 44536890)
24. Dode C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J & Hardelin JP. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genetics 2006 2 e175. (Pubitemid 44656538)
25. Dode C & Hardelin JP. Kallmann syndrome. European Journal of Human Genetics 2009 17 139-146.
26. Sedlmeyer IL & Palmert MR. Delayed puberty: analysis of a large case series from an academic center. Journal of Clinical Endocrinology and Metabolism 2002 87 1613-1620.
27. Miyagawa Y, Tsujimura A, Matsumiya K, Takao T, Tohda A, Koga M, Takeyama M, Fujioka H, Takada S, Koide T & Okuyama A. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. Journal of Urology 2005 173 2072-2075. (Pubitemid 40675246)
28. LaFranchi S, Hanna CE & Mandel SH. Constitutional delay of growth: expected versus final adult height. Pediatrics 1991 87 82-87.
29. Van Dop C, Burstein S, Conte FA & Grumbach MM. Isolated gonadotropin deficiency in boys: clinical characteristics and growth. Journal of Pediatrics 1987 111 684-692. (Pubitemid 18017895)
30. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia- Pinero A, Wolczynski S, Brailly-Tabard S, Bidet M, Arroyo R, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dode C & Young J. A comparative phenotypic study of Kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. Journal of Clinical Endocrinology and Metabolism 2010 95 659-669.
31. Uriarte MM, Baron J, Garcia HB, Barnes KM, Loriaux DL & Cutler GB Jr. The effect of pubertal delay on adult height in men with isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1992 74 436-440.
32. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI & Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Annals of Internal Medicine 1987 106 354-361.
33. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV & Crowley WF Jr. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1989 69 776-783.
34. Behre HM, Kliesch S, Leifke E, Link TM & Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 1997 82 2386-2390.
35. Rezvani I, DiGeorge A, Rutano J & Snyder P. Delayed puberty and anosmia; coincidence or Kallmann variant? (Abstract) Pediatric Research 1975 9 224.
36. Bauman A. Markedly delayed puberty or Kallmann's syndrome variant. Journal of Andrology 1986 7 224-227.
37. Rogol AD, Mittal KK, White BJ, McGinniss MH, Lieblich JM & Rosen SW. HLA-compatible paternity in two "fertile eunuchs" with congenital hypogonadotropic hypogonadism and anosmia (the Kallmann syndrome). Journal of Clinical Endocrinology and Metabolism 1980 51 275-279.
38. Rowe RC, Schroeder ML & Faiman C. Testosterone-induced fertility in a patient with previously untreated Kallmann's syndrome. Fertility and Sterility 1983 40 400-401.
39. Bagatell CJ, Paulsen CA & Bremner WJ. Preservation of fertility despite subnormal gonadotropin and testosterone levels after cessation of pulsatile gonadotropin-releasing hormone therapy in a man with Kallmann's syndrome. Fertility and Sterility 1994 61 392-394.
40. Wortsman J & Hughes LF. Case report: olfactory function in a fertile eunuch with Kallmann syndrome. American Journal of the Medical Sciences 1996 311 135-138.
41. Kadva A, Di WL, Djahanbakhch O, Monson J & Silman R. Evidence for the Bauman variant in Kallmann's syndrome. Clinical Endocrinology 1996 44 103-110.
42. Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC & Jacobs HS. Kallmann's syndrome: is it always for life? Clinical Endocrinology 1999 50 481-485.
43. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr & Pitteloud N. Reversal of idiopathic hypogonadotropic hypogonadism. New England Journal of Medicine 2007 357 863-873.
44. Ribeiro RS, Vieira TC & Abucham J. Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review. European Journal of Endocrinology 2007 156 285-290.
45. Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ & Crowley WF Jr. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. Journal of Clinical Endocrinology and Metabolism 2005 90 1317-1322.
46. Sinisi AA, Asci R, Bellastella G, Maione L, Esposito D, Elefante A, De Bellis A, Bellastella A & Iolascon A. Homozygous mutation in the prokineticin-receptor 2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Human Reproduction 2008 23 2380-2384.
47. Young J, Vincent D, Bachelot A, Kottler ML, Dode C, Plotton I, Chanson P, Pugeat M, Touraine P & Dewailly D. Congenital hypogonadotrophic hypogonadism in women: 1) clinical presentation, hormonal evaluation, 2) ovarian morphological and genetic studies in a series of 104 patients. A multicenter survey. In XXIII Congrès de la Société Française d'Endocrinologie. Montpellier 2006.
48. Perkins RB, Hall JE & Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. Journal of Clinical Endocrinology and Metabolism 1999 84 1905-1911.
49. Young J 2007 Congenital hypogonadotropic hypogonadism. In Endocrinology Treatise. ed 1, ch 86, pp 627-633 Eds P Chanson & J Young. Paris: Flammarion, 2007.
50. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E & Schaison G. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. Journal of Clinical Endocrinology and Metabolism 2000 85 3239-3244.
51. Young J, Chanson P, Salenave S, Noel M, Brailly S, O'Flaherty M, Schaison G & Rey R. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2005 90 724-728.
52. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT & Crowley WF Jr. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2002 87 152-160.
53. Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H & Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2002 87 4128-4136.
54. Young J, Rey R, Couzinet B, Chanson P, Josso N & Schaison G. Antimullerian hormone in patients with hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1999 84 2696-2699.
55. Boukari K, Meduri G, Brailly-Tabard S, Guibourdenche J, Ciampi ML, Massin N, Martinerie L, Picard JY, Rey R, Lombes M & Young J. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. Journal of Clinical Endocrinology and Metabolism 2009 94 1818-1825.
56. Chammas NK, Chambers SM & Harris PE. The GnRH test in the assessment of patients with pituitary and parapituitary lesions: results of a 5-year retrospective study. Pituitary 2008 11 271-278.
57. Adulwahid NA, Armar NA, Morris DV, Adams J & Jacobs HS. Diagnostic tests with luteinising hormone releasing hormone should be abandoned. BMJ 1985 291 1471-1472.
58. Barkan AL, Reame NE, Kelch RP & Marshall JC. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect. Journal of Clinical Endocrinology and Metabolism 1985 61 1118-1125.
59. Young J. Endocrine consequences of hemochromatosis. Presse Médicale 2007 36 1319-1325.
60. Quinton R, Conway GS, Jacobs HS, Bouloux PM & Vanderpump MP. Adult onset idiopathic hypogonadotrophic hypogonadism may be overdiagnosed. BMJ 1998 317 600-601.
61. Quinton R, Beirne P, Bouloux PM, Stanhope RG & Conway GS. Routine neuroimaging in classical isolated gonadotrophin deficiency is of limited clinical value. Clinical Endocrinology 2001 54 127-129.
62. Quinton R, Duke VM, de Zoysa PA, Platts AD, Valentine A, Kendall B, Pickman S, Kirk JM, Besser GM, Jacobs HS & Bouloux PM. The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. Journal of Clinical Endocrinology and Metabolism 1996 81 3010-3017.
63. Jbour AK, Mubaidin AF, Till M, El-Shanti H, Hadidi A & Ajlouni KM. Hypogonadotrophic hypogonadism, short stature, cerebellar ataxia, rod-cone retinal dystrophy, and hypersegmented neutrophils: a novel disorder or a new variant of Boucher-Neuhauser syndrome? Journal of Medical Genetics 2003 40 e2.
64. Hardelin JP, Levilliers J, Young J, Pholsena M, Legouis R, Kirk J, Bouloux P, Petit C & Schaison G. Xp22.3 deletions in isolated familial Kallmann's syndrome. Journal of Clinical Endocrinology and Metabolism 1993 76 827-831.
65. Albuisson J, Pecheux C, Carel JC, Lacombe D, Leheup B, Lapuzina P, Bouchard P, Legius E, Matthijs G, Wasniewska M, Delpech M, Young J, Hardelin JP & Dode C. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Human Mutation 2005 25 98-99.
66. Tsilchorozidou T & Conway GS. Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clinical Endocrinology 2004 61 567-572.
67. Schoot DC, Coelingh Bennink HJ, Mannaerts BM, Lamberts SW, Bouchard P & Fauser BC. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. Journal of Clinical Endocrinology and Metabolism 1992 74 1471-1473.
68. Schoot DC, Harlin J, Shoham Z, Mannaerts BM, Lahlou N, Bouchard P, Bennink HJ & Fauser BC. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Human Reproduction 1994 9 1237-1242.
69. Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr & Hoefsloot LH. CHD7 mutations in patients initially diagnosed with Kallmann syndrome - the clinical overlap with CHARGE syndrome. Clinical Genetics 2009 75 65-71.
70. de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G & Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. New England Journal of Medicine 1997 337 1597-1602.
71. Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC & Neill JD. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nature Genetics 1998 18 14-15.
72. Soderlund D, Canto P, de la Chesnaye E, Ulloa-Aguirre A & Mendez JP. A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene. Clinical Endocrinology 2001 54 493-498.
73. de Roux N, Young J, Brailly-Tabard S, Misrahi M, Milgrom E & Schaison G. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. Journal of Clinical Endocrinology and Metabolism 1999 84 567-572. (Pubitemid 29075685)
74. Caron P, Chauvin S, Christin-Maitre S, Bennet A, Lahlou N, Counis R, Bouchard P & Kottler ML. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. Journal of Clinical Endocrinology and Metabolism 1999 84 990-996. (Pubitemid 29138231)
75. de Roux N, Young J, Misrahi M, Schaison G & Milgrom E. Loss of function mutations of the GnRH receptor: a new cause of hypogonadotropic hypogonadism. Journal of Pediatric Endocrinology and Metabolism 1999 12 (Suppl 1) 267-275. (Pubitemid 29287986)
76. Pralong FP, Gomez F, Castillo E, Cotecchia S, Abuin L, Aubert ML, Portmann L & Gaillard RC. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor. Journal of Clinical Endocrinology and Metabolism 1999 84 3811-3816. (Pubitemid 30645246)
77. Seminara SB, Beranova M, Oliveira LM, Martin KA, Crowley WF Jr & Hall JE. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. Journal of Clinical Endocrinology and Metabolism 2000 85 556-562. (Pubitemid 32273634)
78. Kottler ML, Chauvin S, Lahlou N, Harris CE, Johnston CJ, Lagarde JP, Bouchard P, Farid NR & Counis R. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect. Journal of Clinical Endocrinology and Metabolism 2000 85 3002-3008.
79. Beranova M, Oliveira LM, Bedecarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley WF Jr & Seminara SB. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2001 86 1580-1588. (Pubitemid 32374907)
80. Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF Jr & Hayes FJ. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. Journal of Clinical Endocrinology and Metabolism 2001 86 2470-2475. (Pubitemid 32545694)
81. Costa EM, Bedecarrats GY, Mendonca BB, Arnhold IJ, Kaiser UB & Latronico AC. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. Journal of Clinical Endocrinology and Metabolism 2001 86 2680-2686.
82. Silveira LF, Stewart PM, Thomas M, Clark DA, Bouloux PM & MacColl GS. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR "knockout". Journal of Clinical Endocrinology and Metabolism 2002 87 2973-2977.
83. Dewailly D, Boucher A, Decanter C, Lagarde JP, Counis R & Kottler ML. Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor gene. Fertility and Sterility 2002 77 1288-1291. (Pubitemid 34626345)
84. Wolczynski S, Laudanski P, Jarzabek K, Mittre H, Lagarde JP & Kottler ML. A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene. Fertility and Sterility 2003 79 442-444. (Pubitemid 36144078)
85. Karges B, Karges W, Mine M, Ludwig L, Kuhne R, Milgrom E & de Roux N. Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2003 88 1873-1879.
86. Meysing AU, Kanasaki H, Bedecarrats GY, Acierno JS Jr, Conn PM, Martin KA, Seminara SB, Hall JE, Crowley WF Jr & Kaiser UB. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism 2004 89 3189-3198. (Pubitemid 38951883)
87. Antelli A, Baldazzi L, Balsamo A, Pirazzoli P, Nicoletti A, Gennari M & Cicognani A. Two novel GnRHR gene mutations in two siblings with hypogonadotropic hypogonadism. European Journal of Endocrinology 2006 155 201-205. (Pubitemid 44269435)
88. Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, Van Vliet G, Bouloux P, Hall JE, Hayes FJ, Pitteloud N, Martin KA, Welt C & Seminara SB. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. European Journal of Endocrinology 2006 155 (Suppl 1) S3-S10.
89. Lin L, Conway GS, Hill NR, Dattani MT, Hindmarsh PC & Achermann JC. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia. Journal of Clinical Endocrinology and Metabolism 2006 91 5117-5121.
90. Topaloglu AK, Lu ZL, Farooqi IS, Mungan NO, Yuksel B, O'Rahilly S & Millar RP. Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene. Neuroendocrinology 2006 84 301-308.
91. Quintos JB, Krotz S, Vogiatzi MG, Kralickova M & New MI. Partial hypogonadotropic hypogonadism associated with the Leu266Arg and Gln106Arg mutation of the gonadotropin-releasing hormone receptor. Journal of Pediatric Endocrinology and Metabolism 2009 22 181-185.
92. Karges B, Karges W & de Roux N. Clinical and molecular genetics of the human GnRH receptor. Human Reproduction Update 2003 9 523-530.
93. Bedecarrats GY & Kaiser UB. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. Seminars in Reproductive Medicine 2007 25 368-378.
94. Trarbach EB, Teles MG, Costa EM, Abreu AP, Garmes HM, Guerra G Jr, Baptista MT, de Castro M, Mendonca BB & Latronico AC. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. Clinical Endocrinology 2009 72 371-376.
95. Ulloa-Aguirre A, Janovick JA, Leanos-Miranda A & Conn PM. Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadism. Human Reproduction Update 2004 10 177-192.
96. Janovick JA, Patny A, Mosley R, Goulet MT, Altman MD, Rush TS III, Cornea A & Conn PM. Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor. Molecular Endocrinology 2009 23 157-168.
97. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL & Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS 2003 100 10972-10976.
98. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA & Colledge WH. The GPR54 gene as a regulator of puberty. New England Journal of Medicine 2003 349 1614-1627.
99. Plant TM & Ramaswamy S. Kisspeptin and the regulation of the hypothalamic-pituitary-gonadal axis in the rhesus monkey (Macaca mulatta). Peptides 2009 30 67-75.
100. Colledge WH. Transgenic mouse models to study Gpr54/ kisspeptin physiology. Peptides 2009 30 34-41.
101. Roa J, Aguilar E, Dieguez C, Pinilla L & Tena-Sempere M. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Frontiers in Neuroendocrinology 2008 29 48-69.
102. Wacker JL, Feller DB, Tang XB, Defino MC, Namkung Y, Lyssand JS, Mhyre AJ, Tan X, Jensen JB & Hague C. Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function. Journal of Biological Chemistry 2008 283 31068-31078.
103. Bo-Abbas Y, Acierno JS Jr, Shagoury JK, Crowley WF Jr & Seminara SB. Autosomal recessive idiopathic hypogonadotropic hypogonadism: genetic analysis excludes mutations in the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes. Journal of Clinical Endocrinology and Metabolism 2003 88 2730-2737.
104. Pallais JC, Bo-Abbas Y, Pitteloud N, Crowley WF Jr & Seminara SB. Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54. Molecular and Cellular Endocrinology 2006 254-255 70-77.
105. Lanfranco F, Gromoll J, von Eckardstein S, Herding EM, Nieschlag E & Simoni M. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. European Journal of Endocrinology 2005 153 845-852.
106. Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, O'Rahilly S & Aparicio SA. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2005 90 1849-1855.
107. Tenenbaum-Rakover Y, Commenges-Ducos M, Iovane A, Aumas C, Admoni O & de Roux N. Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54. Journal of Clinical Endocrinology and Metabolism 2007 92 1137-1144.
108. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S & Semple RK. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nature Genetics 2009 41 354-358.
109. Guran T, Tolhurst G, Bereket A, Rocha N, Porter K, Turan S, Gribble FM, Kotan LD, Akcay T, Atay Z, Canan H, Serin A, O'Rahilly S, Reimann F, Semple RK & Topaloglu AK. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. Journal of Clinical Endocrinology and Metabolism 2009 94 3633-3639.
110. Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CV, Jafarzadehshirazi MR, Pereira A, Iqbal J, Caraty A, Ciofi P & Clarke IJ. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 2007 148 5752-5760.
111. Foradori CD, Amstalden M, Goodman RL & Lehman MN. Colocalisation of dynorphin a and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the sheep. Journal of Neuroendocrinology 2006 18 534-541.
112. Burke MC, Letts PA, Krajewski SJ & Rance NE. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: morphologic evidence of interrelated function within the arcuate nucleus. Journal of Comparative Neurology 2006 498 712-726.
113. Krajewski SJ, Anderson MJ, Iles-Shih L, Chen KJ, Urbanski HF & Rance NE. Morphologic evidence that neurokinin B modulates gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat median eminence. Journal of Comparative Neurology 2005 489 372-386.
114. Navarro VM, Gottsch ML, Chavkin C, Okamura H, Clifton DK & Steiner RA. Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. Journal of Neuroscience 2009 29 11859-11866.
115. Young J, Bouligand J, Francou B, Raffin-Sanson ML, Gaillez S, Jeanpierre M, Grynberg M, Kamenicky P, Chanson P, Brailly- Tabard S & Guiochon-Mantel A. TAC3 and TACR3 defects cause congenital hypothalamic hypogonadotropic hypogonadism in humans. Journal of Clinical Endocrinology and Metabolism 2010. In press. DOI:10.1210/jc.2009-2600.
116. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA & Fink G. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 1977 269 338-340.
117. Krieger DT, Perlow MJ, Gibson MJ, Davies TF, Zimmerman EA, Ferin M & Charlton HM. Brain grafts reverse hypogonadism of gonadotropin releasing hormone deficiency. Nature 1982 298 468-471.
118. Charlton H. Neural transplantation in hypogonadal (hpg) mice - physiology and neurobiology. Reproduction 2004 127 3-12.
119. Mason AJ, Hayflick JS, Zoeller RT, Young WS III, Phillips HS, Nikolics K & Seeburg PH. A deletion truncating the gonadotropin- releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986 234 1366-1371.
120. Mason AJ, Pitts SL, Nikolics K, Szonyi E, Wilcox JN, Seeburg PH & Stewart TA. The hypogonadal mouse: reproductive functions restored by gene therapy. Science 1986 234 1372-1378.
121. Son GH, Park E, Jung H, Han J, Lee KH, Seong JY & Kim K. GnRH pre-mRNA splicing: solving the mystery of a nature's knockout, hpg mouse. Biochemical and Biophysical Research Communications 2005 326 261-267.
122. Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombes M, Millar RP, Guiochon-Mantel A & Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. New England Journal of Medicine 2009 360 2742-2748.
123. Charlton HM, Halpin DM, Iddon C, Rosie R, Levy G, McDowell IF, Megson A, Morris JF, Bramwell A, Speight A, Ward BJ, Broadhead J, Davey-Smith G & Fink G. The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. Endocrinology 1983 113 535-544.
124. Stanley HF, Curtis A, Sheward WJ, Roberts JL & Fink G. Prolactin messenger ribonucleic acid levels in the normal and hypogonadal mouse pituitary gland. Endocrinology 1986 119 2422-2426.
125. Moshang T Jr, Marx BS, Cara JF & Snyder PJ. The prolactin response to thyrotropin-releasing hormone does not distinguish teenaged males with hypogonadotropic hypogonadism from those with constitutional delay of growth and development. Journal of Clinical Endocrinology and Metabolism 1985 61 1211-1213.
126. Nikolics K, Mason AJ, Szonyi E, Ramachandran J & Seeburg PH. A prolactin-inhibiting factor within the precursor for human gonadotropin- releasing hormone. Nature 1985 316 511-517.
127. Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N & Seminara SB. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. PNAS 2009 106 11703-11708.
128. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi- Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C & Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nature Genetics 2003 33 463-465. (Pubitemid 36390006)
129. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF Jr, Zhou QY & Pitteloud N. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. Journal of Clinical Endocrinology and Metabolism 2008 93 3551-3559.
130. Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, Kaiser UB, Mohammadi M & Pitteloud N. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2009 94 4380-4390.
131. Kim HG, Kurth I, Lan F, Meliciani I,WenzelW, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ,Walker SL, Shi Y, Gusella JF & Layman LC. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. American Journal of Human Genetics 2008 83 511-519.
132. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M & Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. Journal of Clinical Investigation 2007 117 457-463.